Quick Takeaways
- Michael Richman has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Michael Richman
- Location
- Houston, TX
- Signature
- /s/ Steven P. Cobourn, as attorney-in-fact for Michael Richman
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Michael Richman and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: NextCure, Inc. ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Michael Richman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NXTC | NextCure, Inc. | President & CEO, Director | 30 Jan 2026 | |||
| PVLA | PIERIS PHARMACEUTICALS, INC. | Director | 21 Jun 2023 |
Insider Transactions Reported by Michael Richman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.